Recent Updates
Recently added Catalysts
PTN Positive Sentiment Score: 60/100

Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results

Key Takeaway: Palatin Technologies, Inc. is scheduled to announce its fourth quarter and fiscal year end 2024 operating results on October 1, 2024. The company will host a conference call at 11:00 AM ET to review the results and update on ongoing development programs. This event aims to provide transparency to investors about the company's performance and future direction.

Market Sentiment Analysis

POSITIVE FACTORS

  • Palatin will report financial results showing potential growth.
  • The teleconference may provide insights into future programs.
  • The company focuses on first-in-class medicines addressing unmet medical needs.

Full Press Release Details

Teleconference and Webcast to be held on October 1, 2024
CRANBURY, N.J., Sept. 26, 2024 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2024 operating results on Tuesday, October 1, 2024, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on October 1, 2024 at 11:00 AM Eastern Time. The conference call will include a review of the company's operating results and an update on programs under development.
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast
Q4 & Fiscal Year End 2024 Results Press Release 10/01/2024 at 7:30 a.m. ET
Q4 & Fiscal Year End 2024 Conference Call-Live 10/01/2024 at 11:00 a.m. ET
US Toll Free Dial-In Number: 1-888-506-0062
International Dial-In Number: 1-973-528-0011
Participant Access Code: 252326
Q4 & Fiscal Year End 2024 Conference Call-Replay 10/01/2024-10/15/2024
US Toll Free Dial-In Number: 1-877-481-4010
International Dial-In Number: 1-919-882-2331
Participant Access Code: 51290
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
SOURCE Palatin Technologies, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Palatin announce Q4 2024 results?

Palatin will announce its Q4 2024 results on October 1, 2024, before market opening.

What time is the conference call on October 1, 2024?

The conference call will take place at 11:00 AM Eastern Time on October 1, 2024.

How can I access the conference call replay?

You can access the replay from October 1 to October 15, 2024, using specific dial-in numbers.

Where can I find the audio webcast?

The audio webcast can be found in the 'Investors-Webcasts' section on Palatin's website.

What does Palatin Technologies focus on?

Palatin develops first-in-class medicines targeting melanocortin receptor systems for unmet medical needs.

Last updated: Sep 26, 2024